Back to Journals » Drug Design, Development and Therapy » Volume 13
20(S)-Ginsenoside Rg3 Promotes Senescence And Apoptosis In Gallbladder Cancer Cells Via The P53 Pathway [Corrigendum]
Authors Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X, Xiang S, Li H, Jiang L, Tan Z, Lu W, Weng H, Shu Y, Gong W, Wang X, Zhang Y, Shi W, Dong P, Gu J, Liu Y
Received 12 September 2019
Accepted for publication 12 September 2019
Published 8 October 2019 Volume 2019:13 Pages 3527—3528
Zhang F, Li M, Wu X, et al. Drug Des Devel Ther. 2015;9:3969–3987.
On page 3976, Figure 3B should be presented as follows: Following a review of the data post-publication, the authors found two identical cell cycle images in two different groups were placed for 200μM and 400μM. We have replaced the image for 400μM in this corrigendum.
The authors confirmed that this error does not affect any statistical results or any relevant conclusions about Figure 3B. The authors apologize for this oversight.
Read the original article here
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.